These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 6319045)
1. Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure. Levine TB; Olivari MT; Garberg V; Sharkey SW; Cohn JN Circulation; 1984 Mar; 69(3):548-53. PubMed ID: 6319045 [TBL] [Abstract][Full Text] [Related]
2. Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations. DiCarlo L; Chatterjee K; Parmley WW; Swedberg K; Atherton B; Curran D; Cucci M J Am Coll Cardiol; 1983 Nov; 2(5):865-71. PubMed ID: 6313787 [TBL] [Abstract][Full Text] [Related]
3. Enalapril (MK-421), a new angiotensin-converting enzyme inhibitor. Acute and chronic effects in heart failure. Dunkman WB; Wilen M; Franciosa JA Chest; 1983 Nov; 84(5):539-45. PubMed ID: 6313304 [TBL] [Abstract][Full Text] [Related]
4. Acute and chronic hemodynamic effects of enalapril (MK-421) in congestive heart failure. Dickstein K; Søyland E; Gundersen T; Abrahamsen AM; Kjekshus J Int J Cardiol; 1984 Oct; 6(4):445-58. PubMed ID: 6092286 [TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril). Fouad FM; Tarazi RC; Bravo EL; Textor SC Hypertension; 1984; 6(2 Pt 1):167-74. PubMed ID: 6327515 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure. Cody RJ; Covit AB; Schaer GL; Laragh JH J Am Coll Cardiol; 1983 Apr; 1(4):1154-9. PubMed ID: 6187789 [TBL] [Abstract][Full Text] [Related]
7. Enalapril in congestive heart failure: acute hemodynamic and neurohumoral evaluation and short-term follow-up. Lin M; Chiang HT; Chang MS; Kong CW; Wang SP; Chiang BN Zhonghua Yi Xue Za Zhi (Taipei); 1991 Jul; 48(1):31-40. PubMed ID: 1679372 [TBL] [Abstract][Full Text] [Related]
8. Clinical and hemodynamic experience with enalapril in congestive heart failure. Cody RJ Am J Cardiol; 1985 Jan; 55(2):36A-40A. PubMed ID: 2981464 [TBL] [Abstract][Full Text] [Related]
9. Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure. Nicod P; Waeber B; Bussien JP; Goy JJ; Turini G; Nussberger J; Hofbauer KG; Brunner HR Am J Cardiol; 1985 Apr; 55(8):1043-7. PubMed ID: 3885704 [TBL] [Abstract][Full Text] [Related]
10. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283 [TBL] [Abstract][Full Text] [Related]
11. Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure. Creager MA; Massie BM; Faxon DP; Friedman SD; Kramer BL; Weiner DA; Ryan TJ; Topic N; Melidossian CD J Am Coll Cardiol; 1985 Jul; 6(1):163-73. PubMed ID: 2989349 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and regional blood flow response to captopril in congestive heart failure. Levine TB; Olivari MT; Cohn JN Am J Med; 1984 May; 76(5B):38-42. PubMed ID: 6375361 [TBL] [Abstract][Full Text] [Related]
13. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril. Turini GA; Waeber B; Brunner HR Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835 [TBL] [Abstract][Full Text] [Related]
14. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. Hall D; Zeitler H; Rudolph W J Am Coll Cardiol; 1992 Dec; 20(7):1549-55. PubMed ID: 1452929 [TBL] [Abstract][Full Text] [Related]
15. Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure. Fitzpatrick D; Nicholls MG; Ikram H; Espiner EA Br Heart J; 1983 Aug; 50(2):163-9. PubMed ID: 6309203 [TBL] [Abstract][Full Text] [Related]
16. Acute and long-term response to enalapril in congestive failure. Kjekshus JK; Søyland E; Dickstein K; Abrahamsen AM; Gundersen T Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):169S-174S. PubMed ID: 6099734 [TBL] [Abstract][Full Text] [Related]
17. Effects of a new angiotensin converting enzyme inhibitor, enalapril, in acute and chronic left ventricular failure in dogs. Leddy CL; Wilen M; Franciosa JA J Clin Pharmacol; 1983; 23(5-6):189-98. PubMed ID: 6308067 [TBL] [Abstract][Full Text] [Related]
18. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure. Pacher R; Stanek B; Globits S; Berger R; Hülsmann M; Wutte M; Frey B; Schuller M; Hartter E; Ogris E Eur Heart J; 1996 Aug; 17(8):1223-32. PubMed ID: 8869864 [TBL] [Abstract][Full Text] [Related]
19. Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responses. Uretsky BF; Shaver JA; Liang CS; Amin D; Shah PK; Levine TB; Walinsky P; LeJemtel T; Linnemeier T; Rush JE Am Heart J; 1988 Aug; 116(2 Pt 1):480-8. PubMed ID: 2840815 [TBL] [Abstract][Full Text] [Related]
20. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure. Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]